Coronavirus Main Protease | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

34,560 results for “Coronavirus Main Protease”

Trials

View all 32380 →

T Cell Therapy Opposing Novel COVID-19 Infection in Immunocompromised Patients

24 participants · First posted Dec 2, 2021

Fosamprenavir Versus Other Protease Inhibitors

314 participants · First posted Oct 21, 2004

Comparative Tolerability of Protease Inhibitors

26,000 participants · First posted Oct 12, 2011

Drugs

View all 322 →

Coronavirus protease inhibitor(Exscientia)

N-3

SARS-CoV2 main protease inhibitor (MERS/COVID 19)

Organizations

View all 273 →

TATA MAIN HOSPITAL

India

MAIN LINE HEALTH CENTER

United States

Main Line Health System

United States

News

View all 1585 →

Inductive Bio Secures $25M Series A to Revolutionize Small Molecule Drug Discovery with AI

Sunshine Biopharma Secures Patent for Novel Coronavirus Treatment Targeting Viral Immune Suppression

Enanta Pharmaceuticals Files Patent Infringement Lawsuit Against Pfizer Over Paxlovid

Page 1 of 3456